Microbot Medical Inc.MBOTNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
15.83%
↓ 18% below average
Average (9y)
19.25%
Historical baseline
Range
High:123.53%
Low:-96.17%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 15.83% |
| 2023 | -26.01% |
| 2022 | 25.73% |
| 2021 | 81.18% |
| 2020 | 14.27% |
| 2019 | 3.95% |
| 2018 | 123.53% |
| 2017 | 14.81% |
| 2016 | 35.36% |
| 2015 | -96.17% |